What Sunshine Biopharma Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 1 | 2 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 58,300 | 158,300 |
| Disposed | 0 | 0 |
| Net activity | +58,300 | +158,300 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Natan David | Director | Aug 07 | Grant / award · A | +58,300 | — | — | 68,300 |
| Natan David | Director | Apr 14 | Grant / award · A | +100,000 | — | — | 100,000 |
| Slilaty Steve N. | Chief Executive Officer | Mar 04 | Open-market buy · P | +100,000 | $0.10 | +$10K | 130,000 |
| Slilaty Steve N. | Chief Executive Officer | Feb 08 | Open-market buy · P | +20,000 | $0.10 | +$2K | 30,000 |
| Sebaaly Camille | CFO/Secretary | Nov 30 | Open-market buy · P | +30,000 | $0.76 | +$22.9K | 174,465 |
| Sebaaly Camille | CFO/Secretary | Jun 03 | Open-market buy · P | +25,000 | $1.22 | +$30.5K | 144,465 |
| Slilaty Steve N. | Chief Executive Officer | Feb 18 | Disposition to Issuer · D | −990,000 | $0.10 | −$99K | 10,000 |
| Merzouki Abderrazzak | Chief Operating Officer | Jan 06 | Grant / award · A | +20,000,000 | $0.00 | +$20K | 23,342,500 |
| Sebaaly Camille | CFO/Secretary | Jan 06 | Grant / award · A | +20,000,000 | $0.00 | +$20K | 23,893,086 |
| Slilaty Steve N. | Chief Executive Officer | Jan 06 | Grant / award · A | +20,000,000 | $0.00 | +$20K | 23,343,461 |
| Slilaty Steve N. | Chief Executive Officer | Jun 17 | Grant / award · A | +500,000 | $0.10 | +$50K | 1,000,000 |
| Slilaty Steve N. | Chief Executive Officer | Dec 31 | Other Transaction · J | +323,673 | $0.00 | +$324 | 861,209 |
| Sebaaly Camille | CFO/Secretary | Dec 31 | Grant / award · A | −323,673 | $0.00 | −$324 | 0 |
| Merzouki Abderrazzak | Chief Operating Officer | Dec 19 | Grant / award · A | +1,300,000 | $0.00 | +$1.3K | 3,342,500 |
| Slilaty Steve N. | Chief Executive Officer | Dec 19 | Grant / award · A | +1,300,000 | $0.00 | +$1.3K | 3,343,461 |
| Sebaaly Camille | CFO/Secretary | Dec 19 | Grant / award · A | +1,300,000 | $0.00 | +$1.3K | 3,893,086 |
| Merzouki Abderrazzak | Chief Operating Officer | Oct 20 | Grant / award · A | +1,100,000 | $0.00 | +$1.1K | 2,042,500 |
| Slilaty Steve N. | Chief Executive Officer | Oct 20 | Grant / award · A | +1,100,000 | $0.00 | +$1.1K | 2,043,461 |
| Sebaaly Camille | CFO/Secretary | Oct 20 | Grant / award · A | +1,100,000 | $0.00 | +$1.1K | 2,593,086 |
| Sebaaly Camille | Secretary | Sep 11 | Grant / award · A | +11,000,000 | $0.00 | +$11K | 29,861,719 |
Loading...
